Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review.
Minnee RC, Fieuws S, Jochmans I, Aerts R, Sainz Barriga M, Debaveye Y, Maertens J, Vandenberghe P, Laleman W, van der Merwe S, Verslype C, Cassiman D, Ferdinande P, Nevens F, Pirenne J, Monbaliu D.
Minnee RC, et al. Among authors: fieuws s.
Am J Transplant. 2018 Dec;18(12):3007-3020. doi: 10.1111/ajt.14923. Epub 2018 Jun 23.
Am J Transplant. 2018.
PMID: 29734503
Free article.